home / stock / tnxp / tnxp articles


TNXP Articles, Tonix Pharmaceuticals Holding Corp. - From 03/28/24

Stock Information

Company Name: Tonix Pharmaceuticals Holding Corp.
Stock Symbol: TNXP
Market: NASDAQ

Menu

TNXP TNXP Quote TNXP Short TNXP News TNXP Articles TNXP Message Board
Get TNXP Alerts

News, Short Squeeze, Breakout and More Instantly...

Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated | Benzinga

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pric...

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring | Benzinga

Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Appl...

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT | Benzinga

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its business show that will air as ...

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series | Benzinga

NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- FMW Media Work announces that its "New to The Street Leadership," Powered by Sector SPDR ETF...

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT | Benzinga

NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television producti...

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. | Benzinga

CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a biopharmaceutical c...

Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting | Benzinga

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 30.8% to $0.41 during Wednesday's session after the company annou...

Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million | Benzinga

Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of ...

Tonix Pharmaceuticals to Present at The National Academies Committee on the Current State of Research, Development, and Stockpiling of Smallpox Medical Countermeasures Public Meeting | Benzinga

CHATHAM, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with marketed pr...

Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December | Benzinga

CHATHAM, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with marketed pr...

Previous 10 Next 10